RYBREVANT FASPRO™ Receives FDA Approval for First-Line EGFR-Mutated NSCLC
December 26, 2025
Brand Name :
Masteron
Synonyms :
drostanolone
Class :
Androstanes, Steroids
Dosage Forms & Strengths
Injectable solution
1.4 mg/kg
1.4 mg/kg is given intramuscularly thrice a week
Pediatric
Not determined
Refer to the adult dosing regimen
Actions and spectrum
Drostanolone has anabolic properties; thus, it can stimulate protein synthesis and promote muscle growth.
Frequency not defined
Facial hair
Coarser skin
Hypertriglyceridemia
Hoarseness
Coarser skin
Black box warning
None
Contraindication/Caution:
The drug is contraindicated in following situations:
Hypersensitivity
Prostate Cancer
Breast Cancer
Pregnancy Warnings:
Pregnancy category: N/A
Lactation:
Excretion of the drug in human breast milk is unknown
Pregnancy categories:
Category A: Satisfactory and well-controlled studies show no evidence of risk to the fetus in the first trimester or in the later trimester.
Category B: No evidence of risk to fetus found in animal reproduction studies and there are not enough studies on pregnant women.
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women.
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits.
Category X: Drugs listed in this category clearly outweigh risks over benefits. These category drugs should be prohibited for pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology:
This drug is derived from dihydrotestosterone. It works by binding it to androgen receptors.
Pharmacodynamics:
The anabolic properties of drostanolone stimulate protein synthesis and promote skeletal muscle growth.
Pharmacokinetics:
Limited information is available on ADME.
Administration:
It is administered into the muscles, i.e., intramuscular route, as an injection.
Patient information leaflet
Generic Name: drostanolone
Why do we use drostanolone?
It is used to treat postmenopausal breast carcinoma.
It gives a muscular appearance to the muscles due to its anabolic androgenic steroid class.